glp 1 anesthesia guidelines 2025 glp-1 Indications for GLP-1/GIP RA Summary Sheet and Beyond! Perioperative management of patients taking

SGLT-2 inhibitors cause robust reduction of HHF and the renal outcome, and moderate reduction of CV or total deaths and MACE [13]

They may help patients eat less without feeling constantly deprived, reduce food noise, improve portion control, and maintain better consistency over time

For weight management, only semaglutide (Wegovy) and liraglutide (Saxenda) are specifically licensed in the UK

The SUSTAIN-6 Trial (Once-Weekly Semaglutide) The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) consisted of 3297 people living with T2DM, 83% with established cardiovascular disease, receiving once-weekly semaglutide (0.5 and 1.0 mg) or placebo

see also review by Brierley & de Lartigue, 2021), or even elsewhere close to the circulation, which in turn release glutamate and peptide cotransmitters within the lower brainstem to convey postprandial satiation signals to the CNS (Figure 1)